The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec
Open accessAbstract
To explore the genetic abnormalities that cooperate with AML1-ETO ( AE ) fusion gene to cause acute myeloid leukemia (AML) with t(8;21), we screened a number of candidate genes and identified 11 types of mutations in C-KIT gene ( mC-KIT ), including 6 previously undescribed ones among 26 of 54 (48.1%) cases with t(8;21). To address a possible chronological order between AE and mC-KIT, we showed that, among patients with AE and mC-KIT , most leukemic cells at disease presentation harbored both genetic alteration, whereas in three such cases investigated during complete remission, only AE , but not mC-KIT , could be detected by allele-specific PCR. Therefore, mC-KIT should be a subsequent event on the basis of t(8;21). Furthermore, induced expression of AE in U937-A/E cells significantly up-regulated mRNA and protein levels of C-KIT. This may lead to an alternative way of C-KIT activation and may explain the significantly higher C-KIT expression in 81.3% of patients with t(8;21) than in patients with other leukemias. These data strongly suggest that t(8;21) AML follows a stepwise model in leukemogenesis, i.e., AE represents the first, fundamental genetic hit to initiate the disease, whereas activation of the C-KIT pathway may be a second but also crucial hit for the development of a full-blown leukemia. Additionally, Gleevec suppressed the C-KIT activity and induced proliferation inhibition and apoptosis in cells bearing C-KIT N822K mutation or overexpression, but not in cells with D816 mC-KIT . Gleevec also exerted a synergic effect in apoptosis induction with cytarabine, thus providing a potential therapeutic for t(8;21) leukemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
Oncogenic Transcription Factors in the Human Acute Leukemias
Look, A. T. (1997) · Science · doi:10.1126/science.278.5340.1059 · Cited by 1,187
G ENETICS OF M YELOID L EUKEMIAS
Kelly, L. M., & Gilliland, D. G. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.032802.115046 · Cited by 523
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia
Pabst, T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, T., Behre, G., Hiddemann, W., Zhang, D.-E., & Tenen, D. G. (2001) · Nature Medicine · doi:10.1038/86515 · Cited by 463
Higuchi, M., O'Brien, D., Kumaravelu, P., Lenny, N., Yeoh, E.-J., & Downing, J. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00016-8 · Cited by 440
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C. J., Burel, S. A., Lagasse, E., Weissman, I. L., Akashi, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171321298 · Cited by 431
Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B., Harada, H., Lenny, N., Downing, J. R., Meyers, S., & Hiebert, S. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6470-6483.2001 · Cited by 339
Care, R. S., Valk, P. J. M., Goodeve, A. C., Abu‐Duhier, F. M., Geertsma‐Kleinekoort, W. M. C., Wilson, G. A., Gari, M. A., Peake, I. R., Löwenberg, B., & Reilly, J. T. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04362.x · Cited by 323
The 8;21 translocation in leukemogenesis
Peterson, L. F., & Zhang, D.-E. (2004) · Oncogene · doi:10.1038/sj.onc.1207727 · Cited by 302
C-kit mutations in core binding factor leukemias
Beghini, A., Peterlongo, P., Ripamonti, C. B., Larizza, L., Cairoli, R., Morra, E., & Mecucci, C. (2000) · Blood · doi:10.1182/blood.v95.2.726 · Cited by 299
Nucifora, G., Larson, R., & Rowley, J. (1993) · Blood · doi:10.1182/blood.v82.3.712.712 · Cited by 291
Frost, M. J., Ferrao, P. T., Hughes, T. P., & Ashman, L. K. (2002) · PubMed · Cited by 281
Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model
Rhoades, K. L., Hetherington, C. J., Harakawa, N., Yergeau, D. A., Zhou, L., Liu, L.-Q., Little, M.-T., Tenen, D. G., & Zhang, D.-E. (2000) · Blood · doi:10.1182/blood.v96.6.2108 · Cited by 257
Vangala, R. K., Heiss-Neumann, M. S., Rangatia, J. S., Singh, S. M., Schoch, C., Tenen, D. G., Hiddemann, W., & Behre, G. (2003) · Blood · doi:10.1182/blood-2002-04-1288 · Cited by 245
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
Mulloy, J. C., Cammenga, J., MacKenzie, K. L., Berguido, F. J., Moore, M. A. S., & Nimer, S. D. (2002) · Blood · doi:10.1182/blood.v99.1.15 · Cited by 208
Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4789.bloodjournal87114789 · Cited by 195
The AML1/ETO fusion protein activates transcription of BCL-2
Klampfer, L., Zhang, J., Zelenetz, A. O., Uchida, H., & Nimer, S. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14059 · Cited by 182
Beghini, A., Ripamonti, C. B., Cairoli, R., Cazzaniga, G., Colapietro, P., Elice, F., Nadali, G., Grillo, G., Haas, O. A., Biondi, A., et al. (2004) · PubMed · Cited by 181
de Guzman, C. G., Warren, A. J., Zhang, Z., Gartland, L., Erickson, P., Drabkin, H., Hiebert, S. W., & Klug, C. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5506-5517.2002 · Cited by 171
Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation
Burel, S. A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D. G., & Zhang, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5577-5590.2001 · Cited by 164
Grisolano, J. L., O’Neal, J., Cain, J., & Tomasson, M. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1531730100 · Cited by 152
Mao, S. S., Frank, R. C., Zhang, J. C., Miyazaki, Y., & Nimer, S. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3635 · Cited by 147
Class III receptor tyrosine kinases: role in leukaemogenesis
Reilly, J. T. (2002) · British Journal of Haematology · doi:10.1046/j.0007-1048.2001.03294.x · Cited by 143
Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia
Kindler, T., Breitenbuecher, F., Marx, A., Beck, J., Heß, G., Weinkauf, B., Duyster, J., Peschel, C., Kirkpatrick, C. J., Theobald, M., et al. (2004) · Blood · doi:10.1182/blood-2003-06-2071 · Cited by 142
Rhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G., & Zhang, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11895 · Cited by 129
Mulloy, J. C., Cammenga, J., Berguido, F. J., Wu, K., Zhou, P. H., Comenzo, R. L., Jhanwar, S. C., Moore, M. A. S., & Nimer, S. D. (2003) · Blood · doi:10.1182/blood-2003-05-1762 · Cited by 127
Buchholz, F., Refaeli, Y., Trumpp, A., & Bishop, J. M. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd027 · Cited by 108
Jakubowiak, A. J., Pouponnot, C., Berguido, F. J., Frank, R. C., Mao, S. S., Massagué, J., & Nimer, S. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000485200 · Cited by 105
Christensen, U., Jacobsen, N., Rajwanshi, V. K., Wengel, J., & Koch, T. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540481 · Cited by 103
Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice
Fenske, T. S., Pengue, G., Mathews, V., Hanson, P. T., Hamm, S. E., Riaz, N., & Graubert, T. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400751101 · Cited by 101
McNeil, S. M., Zeng, C., Harrington, K. S., Hiebert, S. W., Lian, J. B., Stein, J. L., van Wijnen, A. J., & Stein, G. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14882 · Cited by 101
Shimada, H., Ichikawa, H., Nakamura, S., Katsu, R., Iwasa, M., Kitabayashi, I., & Ohki, M. (2000) · Blood · doi:10.1182/blood.v96.2.655 · Cited by 100
AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression.
Reuss-Borst, M. A., Bühring, H. ‐., Schmidt, H., & Müller, C. A. (1994) · PubMed · Cited by 82
Xu, L., Zhao, W.-L., Xiong, S.-M., Su, X.-Y., Zhao, M., Wang, C., Gao, Y.-R., Niu, C., Cao, Q., Gu, B.-W., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402205 · Cited by 74
Self-citationHeinrich, M., Dooley, D., & Keeble, W. W. (1995) · Blood · doi:10.1182/blood.v85.7.1769.bloodjournal8571769 · Cited by 71
Beghini, A., Magnani, I., Ripamonti, C. B., & Larizza, L. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200168 · Cited by 69
The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells
Tonks, A., Pearn, L., Tonks, A. J., Pearce, L., Hoy, T. G., Phillips, S., Fisher, J., Downing, J. R., Burnett, A. K., & Darley, R. L. (2002) · Blood · doi:10.1182/blood-2002-06-1732 · Cited by 68
Shimizu, K., Kitabayashi, I., Kamada, N., Abe, T., Maseki, N., Suzukawa, K., & Ohki, M. (2000) · Blood · doi:10.1182/blood.v96.1.288 · Cited by 66
The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1
Frank, R. C., Sun, X., Berguido, F. J., Jakubowiak, A. J., & Nimer, S. D. (1999) · Oncogene · doi:10.1038/sj.onc.1202459 · Cited by 66
Elsässer, A., Franzen, M., Kohlmann, A., Weisser, M., Schnittger, S., Schoch, C., Reddy, V. A., Burel, S., Zhang, D., Ueffing, M., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206673 · Cited by 62
Blazej, R. G., Paegel, B. M., & Mathies, R. A. (2003) · Genome Research · doi:10.1101/gr.396203 · Cited by 41
Cole, S. R., Aylett, G. W., Harvey, N. L., Cambareri, A. C., & Ashman, L. (1996) · PubMed · Cited by 38
de Vos, S., Brach, M. A., Asano, Y., et al. (1993) · PubMed · Cited by 36
Cited by
Thiede, C., Koch, S., Creutzig, E., Steudel, C., Illmer, T., Schaich, M., Ehninger, G., & (DSIL), F. T. D. S. L. (2006) · Blood · doi:10.1182/blood-2005-08-3167 · Cited by 736
Paschka, P., Marcucci, G., Ruppert, A. S., Mrózek, K., Chen, H., Kittles, R. A., Vukosavljevic, T., Perrotti, D., Vardiman, J. W., Carroll, A. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9500 · Cited by 663
Miettinen, M., & Lasota, J. (2005) · Applied Immunohistochemistry & Molecular Morphology · doi:10.1097/01.pai.0000173054.83414.22 · Cited by 556
Schittenhelm, M. M., Shiraga, S., Schroeder, A., Corbin, A. S., Griffith, D., Lee, F. Y., Bokemeyer, C., Deininger, M. W. N., Druker, B. J., & Heinrich, M. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2050 · Cited by 468
Xiong, H., Zhang, Z.-G., Tian, X.-Q., Sun, D.-F., Liang, Q.-C., Zhang, Y.-J., Lu, R., Chen, Y.-X., & Fang, J.-Y. (2008) · Neoplasia · doi:10.1593/neo.07971 · Cited by 426
Metadata
- Authors
- Wang, Y.-Y., Zhou, G.-B., Yin, T., Chen, B., Shi, J.-Y., Liang, W.-X., Jin, X.-L., You, J.-H., Yang, G., Shen, Z.-X., Chen, J., Xiong, S.-M., Chen, G.-Q., Xu, F., Liu, Y.-W., Chen, Z., & Chen, S.-J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-01-13
- Volume
- 102
- Issue
- 4
- Pages
- 1104-1109
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2095023562
- Cited by
- 276
- References
- 44
- FWCI
- 18.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.